Dermatomyositis: Evolution of a diagnosis

Physical Therapy

Volumn 83, Issue 10, 2003, Pages 932-945

  Cleland, Joshua A ^a,b   Venzke, Jane Walter ^a  

^a FRANKLIN PIERCE COLLEGE   (United States)

^b New Hampshire Dartmouth Psychiatric Research Center   (United States)

Author keywords

Dermatomyositis; Diagnosis; Inflammatory myopathies; Physical therapy

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DERMATOMYOSITIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EXERCISE; FEMALE; HEALTH SURVEY; HUMAN; INFLAMMATION; MUSCLE STRENGTH; MUSCLE STRETCHING; MUSCULOSKELETAL DISEASE; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PATIENT REFERRAL; PHYSIOTHERAPIST; RHEUMATOLOGY; SKIN DISEASE; SYMPTOMATOLOGY; SYSTEMIC DISEASE;

EID: 0141962519     PISSN: 00319023     EISSN: None     Source Type: Journal    
DOI: 10.1093/ptj/83.10.932     Document Type: Article

References (58)

1. Daker-White G, Carr AJ, Harvey I, et al. A randomised controlled trial: shifting boundaries of doctors and physiotherapists in orthopaedic outpatient departments. J Epidemiol Community Health. 1999;53: 643-650.
2. Boissonault B, Bass T. Medical screening examination: not optional for physical therapists. J Orthop Sports Phys Ther. 1991;14:241-242.
3. Sackett DL, Rennie D. The science and art of the clinical examination. JAMA. 1992;267:2650-2652.
4. Delitto A, Snyder-Mackler L. The diagnosis process: examples in orthopedic physical therapy. Phys Ther. 1995;75:203-211.
5. Echternach JL, Rothstein JM. Hypothesis-oriented algorithms. Phys Ther. 1989;69:559-564.
6. Goodman CC, Snyder TE. Differential Diagnosis in Physical Therapy. Philadelphia, Pa: WB Saunders Co; 2000.
7. Mehta DP, Wortmann RL. Management guidelines for idiopathic inflammatory myopathies. J Musculoskeletal Med. 1994;11(9):38-43.
8. Wortmann RL. Inflammatory diseases of muscle and other myopathies. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of Rheumatology. 5th ed. Philadelphia, Pa: WB Saunders Co; 1997: 1177-1206.
9. Brown CB, Marschall SF. Connective tissue disease update: focus on dermatomyositis. Consultant. October 1999:2867-2875.
10. Heikkila S, Viitanen JV, Kautiainen H, et al. Rehabilitation in myositis. Physiotherapy. 2001;87:301-309.
11. Wortmann RL. Myopathic diseases. Bull Rheum Dis. 2002;51 (3):1-3.
12. Leff RL, Kurrent JE, Dickoff DJ. Polymyositis and dermatomyositis: meeting the diagnostic challenge. J Musculoskeletal Med. 1994;11(4): 57-68.
13. Provost TT, Flynn JA. Dermatomyositis. In: Provost TT, Flynn JA, eds. Cutaneous Medicine: Cutaneous Manifestations of Systemic Disease. Hamilton, Ontario, Canada: BC Decker Inc; 2000:82-104.
14. Kroll M, Otis J, Kagen L. Serum enzyme, myoglobin, and muscle strength relationships in polymyositis and dermatomyositis. J Rheumatol 1986;13:349-355.
15. Stoll T, Bruhlmann P, Stucki G, et al. Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical course of a new, quantitative, easily applicable method. J Rheumatol. 1995;22:473-477.
16. Callen JP. Dermatomyositis. Lancet. 2000;355:53-57.
17. Kasteler JS, Callen JP. Scalp involvement in dermatomyositis: often overlooked or misdiagnosed. JAMA. 1994;272:1939-1941.
18. Soter NA, Franks AG. Cutaneous manifestations of rheumatic diseases. In: Kelly WN, Ruddy S, Harris ED, Sledge CB, eds. Textbook of Rheumatology. 5th ed. Philadelphia, Pa: WB Saunders Co; 1997:504.
19. Dalkas MC. Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med. 1991;324:1487-1499.
20. Airio A, Pukkala E, Isomaki H. Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol 1995;22: 1300-1303.
21. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:403-407.
22. Guide to Physical Therapist Practice. 2nd ed. Alexandria, Va: American Physical Therapy Association; 2001.
23. Lundeberg T, Lund I, Dahlin L, et al. Reliability and responsiveness of three different pain assessments. J Rehabil Med. 2001;33:279-283.
24. Ferraz MB, Quaresma MR, Aquino LR, et al. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol. 1991;18:1269-1270.
25. Paice JA, Cohen FL. Validity of a verbally administered numeric rating scale to measure cancer pain intensity. Cancer Nurs, 1997;20: 88-93.
26. Magee DJ. Orthopaedic Physical Assessment. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1997.
27. Rothstein JM, Miller PJ, Roettger RF. Goniometric reliability in a clinical setting: elbow and knee measurements. Phys Ther. 1983;63: 11-15.
28. Butler DS. The Sensitive Nervous System. Adelaide, South Australia, Australia: Noigroup Publications; 2000: chap II.
29. Wadsworth CT, Krishanan R, Sear M, et al. Intrarater reliability or manual muscle testing and hand-held dynametric muscle testing. Phys Ther. 1987;67:1342-1347.
30. Meijne W, Neerbos KV, Aufdemkampe G, van der Wurff P. Intraexaminer and interexaminer reliability of the Gillet test. J Manipulative Physiol Ther. 1999;22:4-9.
31. Cyriax JH, Cyriax PJ. Cyriax's Illustrated Manual of Orthopaedic Medicine. Woburn, Mass: Butterworth Heinemann; 2000:6-7.
32. Levangie PK. Four clinical tests of sacroiliac joint dysfunction: the association of test results with innominate torsion among patients with and without low back pain. Phys Ther. 1999;79:1043-1057.
33. Greenman PE. Principles of Manual Medicine. Baltimore, Md: Williams & Wilkins; 1989.
34. Youdas JW, Carey JR, Garrett TR. Reliability of measurements of cervical spine range of motion: comparison of three methods. Phys Ther. 1991;71:98-106.
35. Maitland GD. Peripheral Manipulation. 3rd ed. London, England: Butterworth-Heinemann; 1991.
36. Fjellner A, Bexander C, Falcij R, Strender LE. Interexaminer reliability in physical examination of the cervical spine. J Manipulative Physiol Ther. 1999;22:511-516.
37. Evjenth O, Hamberg J. Muscle Stretching in Manual Therapy: A Clinical Manual. Alfta, Sweden: Alfta Rehab; 1993: chap 2.
38. Flynn TW, Whitman J, Magel J. Orthopaedic Manual Physical Therapy Management of the Cervical-Thoracic Spine and Ribcage. San Antonio, Tex: Manipulations Inc; 2000.
39. Maitland GF. Maitland's Vertebral Manipulation. 6th ed. Woburn, Mass: Butterworth-Heinemann; 2001:170-172.
40. Elveru RA, Rothstein JM, Lamb RL. Goniometric reliability in a clinical setting: subtalar and ankle joint measurements. Phys Ther. 1988;68:672-677.
41. Ellis MI, Stowe J. The hip. Clin Rheum Dis. 1982;8:655-672.
42. Iddings DM, Smith LK, Spencer WA. Muscle testing, part 2: reliability in clinical use. Phys Ther Rev. 1961;41:249-256.
43. Husted JA, Gladman DD, Farewell VT, et al. Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 1997;24:511-517.
44. Kosiniski MM, Keller SD, Ware JE, et al. The SF-36 health survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care. 1999;37:MS23-MS39.
45. Ruta DA, Hurst NP, Kind P, et al. Measuring health status in British patients with rheumatoid arthritis: reliability, validity, and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol. 1998;37:425-436.
46. Escalante A, Miller L, Beardmore TD. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis. J Rheumatol. 1993;20: 1340-1344.
47. Wiesinger GF, Quittan M, Aringer M, et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training program. Br J Rheumatol. 1998;37:196-200.
48. Wiesinger GF, Quittan M, Graninger M, et al. Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol 1998;37:1338-1342.
49. Clarkson PM, Apple FS, Byrnes WC, et al. Creatine kinase isoforms following isometric exercise. Muscle Nerve. 1987;10:41-44.
50. Nicholson GA, Morgan GJ, Meerkin M, et al. The effect of aerobic exercise on serum creatine kinase activities. Muscle Nerve. 1986;9: 820-824.
51. Alexanderson H, Stenstrom CH, Lundberg I. Safety of a home exercise regimen programme in patient with polymyositis and dermatomyositis: a pilot study. Rheumatology. 1999;38:608-611.
52. Koller RA, Montemarano A. Dermatomyositis. Am Fam Physician. 2001;64:1565-1572.
53. Rendt K. Inflammatory myopathies: narrowing the differential diagnosis. Clev Clin J Med. 2001;68:505-519.
54. Klippel JH, ed. Primer on Rheumatic Diseases. Atlanta, Ga: Arthritis Foundation; 1997:276-282.
55. Ciccone CD. Pharmacology in Rehabilitation. Philadelphia, Pa: FA Davis Co; 1996: chap 16.
56. Guccione AA. Physical therapy diagnosis and the relationship between impairments and function. Phys Ther. 1991;71:449-504.
57. Jette AM. Diagnosis and classification by physical therapists: a special communication. Phys Ther. 1989;69:967-969.
58. Rose SJ. Physical therapy diagnosis: role and function. Phys Ther. 1989;69:535-537.